Study to Treat Uveitis Associated Macular Edema

Inclusion Criteria: * Have anterior uveitis, intermediate uveitis, posterior uveitis or panuveitis in at least one eye * Have persistent macular edema and uveitis whose conditions are stable * Have no change in medication regimen for at least 3 months prior to randomization if currently taking medications such as immunosuppressive or anti-inflammatory agents; steroidal or non-steroidal agents (drops, oral or injected) * Have an OCT scan with a qualifying retinal thickness in the study eye * Have evidence of macular edema on OCT scan * Have at lease one eligible eye to be treated in the study based on visual acuity. Exclusion Criteria: * Have proliferative vitreoretinopathy greater than grade B * Have subretinal or vitreous hemorrhage, corneal opacity, or other conditions, which limit the view of the retina or obscure FA * Have uncontrollable elevated IOP, advanced, previous filtration surgery, or any current evidence of endophthalmitis in the study eye * Have ocular disorders in the study eye that may confound interpretation of study results * Have had cataract surgery in the study eye within 3 months, YAG laser capsulotomy within the past 1 month, or any other intraocular surgery within the past 90 days * Have pre-operative spherical equivalent refractive error of more than -10 diopters of myopia in the study eye * Have had any intravitreal or periocular injection or corticosteroids in the study eye during the 3 months prior to screening * Have any ocular implant device for the delivery of therapeutic agents to the eye * Be taking any excluded medications that could obscure or confound study results